Following the recall of the
Stryker Rejuvenate and ABGII hip implant devices in July, 2012, many of the
nearly 20,000 recipients of the recalled implants wondered whether they were at
risk for symptoms of Stryker cobalt toxicity. With a titanium stem and a cobalt
and chromium neck, during periods of physical activity these metal parts rub
against one another, causing tiny metal shards to shear away. Even though
studies done over a decade ago warned against mixing metals, Stryker chose to
pair these dissimilar metals in their new design. The Stryker recall cautioned
patients regarding the risks of fretting and corrosion, leading to the excess
generation of metal debris. While not specifically mentioned, symptoms of
Stryker cobalt toxicity are likely, once the metal implant has begun to shed
these cobalt and chromium ions.
Until metal hip devices began
being implanted, cobalt toxicity was rarely seen other than in industrial
factories. Symptoms of Stryker cobalt toxicity include chronic and severe
headaches, fatigue, nausea, vertigo, memory loss, diminishment of cognitive
functions, hearing and visual impairments, cardiomyopathy, tremors and loss of
coordination, renal failures and anxiety, irritability and depression. While
cobalt is present naturally in the body, those with no unusual environmental
exposure to cobalt will have less than 0.41 micrograms per deciliter of cobalt
in their bloodstream—equal to a tiny grain of sand and not sufficient to cause
symptoms of Stryker cobalt toxicity.
Cobalt levels above 5
micrograms per deciliter in the bloodstream are generally believed to be toxic
to the human body. Following the recall of the Stryker implants and many
reports of symptoms of Stryker cobalt toxicity, most physicians recommend blood
tests every three months for implant recipients. Any patient with worsening hip
or groin pain along with symptoms of Stryker cobalt toxicity should speak with
their doctor in order to determine whether revision surgery is the best course
of action. After ensuring their health is protected, recipients of the recalled
Rejuvenate or ABGII could benefit from speaking to an experienced Stryker
attorney who can assess the individual situation and lay out possible courses
of action.